Home > Journals > International Angiology > Past Issues > International Angiology 2018 December;37(6) > International Angiology 2018 December;37(6):427-30

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

EDITORIAL   Freefree

International Angiology 2018 December;37(6):427-30

DOI: 10.23736/S0392-9590.18.04069-5

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Rivaroxaban for post-discharge thromboprophylaxis: the MARINER trial

Eduardo RAMACCIOTTI , Jawed FAREED

Hemostasis and Thrombosis Research Laboratories, Loyola University Medical Center, Maywood, IL, USA



top of page